National Health Act 1953 Determination under section 93 (PB No. 35 of 2006) (Cth)
COMMONWEALTH OF AUSTRALIA
National Health Act 1953
PHARMACEUTICAL BENEFITS
DETERMINATION UNDER SECTION 93
No. PB 35 of 2006
I, JOAN CORBETT, Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Ageing and Delegate of the Minister for Health and Ageing, pursuant to section 93 of the National Health Act 1953, hereby make the following Determination:
This Determination commences on 1 August 2006.
Determination No. PB 18 of 2006 under section 93 of the National Health Act 1953, made on 24 March 2006 with effect from 1 April 2006, is repealed.
The pharmaceutical benefits referred to in this Determination shall be those specified in the Schedule to this Determination.
A medical practitioner is authorised for the purpose of section 93 of the National Health Act 1953 to supply any of the pharmaceutical benefits obtained by the medical practitioner, or by another medical practitioner for whom the first-named medical practitioner is temporarily acting as a locum, in pursuance of this Determination.
Subject to this Determination, the maximum quantity or number of units of a pharmaceutical benefit which may be obtained by a medical practitioner in any one month for the purpose of section 93 of the National Health Act 1953 is the quantity or number specified in the Schedule to this Determination in relation to the pharmaceutical benefit.
Where a medical practitioner has obtained a pharmaceutical benefit for the purpose of section 93 of the National Health Act 1953, that medical practitioner is not entitled to obtain a further quantity or number of units of that pharmaceutical benefit for that purpose whilst in possession of a quantity or number of units of the pharmaceutical benefit obtained by the medical practitioner equal to or greater than the maximum quantity or number of units allowed for the pharmaceutical benefit by paragraph 5.
THE SCHEDULE
| Name of pharmaceutical benefit | Form (strength, type, size, etc.) | Maximum quantity |
| Adrenaline Acid Tartrate | Injection equivalent to adrenaline 1 in 1,000, 1 mL | 5 |
| Atropine Sulfate | Injection 600 micrograms in 1 mL ampoule | 10 |
| Benztropine Mesylate | Injection 2 mg in 2 mL ampoule | 5 |
| Benzylpenicillin Sodium | Powder for injection equivalent to 600 mg benzylpenicillin | 10 |
| OR | ||
| Procaine Penicillin | Injection 1.5 g in disposable syringe | 5 |
| Benzylpenicillin Sodium | Powder for injection equivalent to 3 g benzylpenicillin | 1 |
| Chlorpromazine Hydrochloride | Injection 50 mg in 2 mL ampoule | 10 |
| OR | ||
| Haloperidol | Injection 5 mg in 1 mL ampoule | 10 |
| Dexamethasone Sodium Phosphate | Injection equivalent to 4 mg dexamethasone phosphate in 1 mL ampoule | 5 |
| OR | ||
| Hydrocortisone Sodium Succinate | Injection equivalent to 100 mg hydrocortisone with 2 mL solvent | 2 |
| OR | ||
| Hydrocortisone Sodium Succinate | Injection equivalent to 250 mg hydrocortisone with 2 mL solvent | 1 |
| Diazepam | Injection 10 mg in 2 mL ampoule | 5 |
| Dihydroergotamine Mesylate | Injection 1 mg in 1 mL ampoule | 5 |
| Diphtheria and Tetanus Vaccine - Adsorbed (Diluted) | Injection 0.5 mL in pre-filled syringe | 20 |
| Frusemide | Injection 20 mg in 2 mL | 5 |
| Glucagon Hydrochloride | Injection set containing 1 mg (1 I.U.) and 1 mL solvent in disposable syringe | 1 |
| Glyceryl Trinitrate | Buccal/sublingual spray (pump pack) 400 micrograms per dose, 200 doses | 1 |
| Lignocaine Hydrochloride | Injection 100 mg in 5 mL | 5 |
| Metoclopramide Hydrochloride | Injection 10 mg in 2 mL ampoule | 10 |
| OR | ||
| Prochlorperazine Mesylate | Injection 12.5 mg in 1 mL ampoule | 10 |
| Morphine Sulfate | Injection 15 mg in 1 mL ampoule | 5 |
| OR | ||
| Morphine Sulfate | Injection 30 mg in 1 mL ampoule | 5 |
| Naloxone Hydrochloride | Injection 800 micrograms in 2 mL disposable injection set | 5 |
| OR | ||
| Naloxone Hydrochloride | Injection 2 mg in 5 mL disposable injection set | 2 |
| Promethazine Hydrochloride | Injection 50 mg in 2 mL ampoule | 10 |
| Salbutamol Sulfate | Pressurised inhalation equivalent to 100 micrograms salbutamol per dose, 200 doses (CFC-free formulation) | 1 |
| OR | ||
| Salbutamol Sulfate | Nebuliser solution equivalent to 2.5 mg salbutamol in 2.5 mL single dose units, 30 | 1 |
| Salbutamol Sulfate | Nebuliser solution equivalent to 5 mg salbutamol in 2.5 mL single dose units, 30 | 1 |
| Terbutaline Sulfate | Injection 500 micrograms in 1 mL ampoule | 5 |
| Tramadol Hydrochloride | Injection 100 mg in 2 mL ampoule | 5 |
| Verapamil Hydrochloride | Injection 5 mg in 2 mL ampoule | 5 |
Dated this 26th day of July 2006.
| JOAN CORBETT Assistant Secretary Pharmaceutical Benefits Branch Department of Health and Ageing Delegate of the Minister for Health and Ageing |
0
0
0